Sol-Gel Technologies

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLGL and other ETFs, options, and stocks.

About SLGL

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.

CEO

Moshe Arkin

CEOMoshe Arkin

Employees

Employees36

Headquarters

Ness Ziona, Tel Aviv

HeadquartersNess Ziona, Tel Aviv

Founded

1997

Founded1997

Employees

Employees36

SLGL Key Statistics

Market cap

21.79M

Market cap21.79M

Price-Earnings ratio

-2.28

Price-Earnings ratio-2.28

Dividend yield

—

Dividend yield—

Average volume

746.32K

Average volume746.32K

High today

$0.7872

High today$0.7872

Low today

$0.701

Low today$0.701

Open price

$0.77

Open price$0.77

Volume

43.69K

Volume43.69K

52 Week high

$1.65

52 Week high$1.65

52 Week low

$0.334

52 Week low$0.334

Sol-Gel Technologies

Why Robinhood?

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. Show more

SLGL Key Statistics

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.